The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia

The First Case of Haemophagocytic Lymphohistiocytosis Triggered by the Booster Dose of Anti-SARS-CoV-2 Vaccine in a Patient with β-Thalassemia

Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare and potentially life-threatening systemic hyperinflammatory disease, which can have several aetiologies. Clinical case: a 48-year-old woman affected by a transfusion-dependent β-thalassemia was hospitalized in our haematology unit prese...

Full description

Bibliographic Details
Main Authors: Giuseppina Calvaruso, Marta Chiavetta, Disma Renda, Simona Raso, Francesco Dieli, Vincenzo Luca Lentini, Massimo Gentile, Antonio Carroccio, Aurelio Maggio
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Thalassemia Reports
Subjects:
thalassemia
haemophagocytic lymphohistiocytosis
SARS-CoV-2
vaccine
Online Access:https://www.mdpi.com/2039-4365/12/2/9

Internet

https://www.mdpi.com/2039-4365/12/2/9

Similar Items